25/11/2025
New data out this week just reinforces what obesity medicine has been saying for years: GLP-1s are chronic-disease meds. When people stop them, they typically regain a significant amount of weight and lose many of the cardiometabolic benefits.
For many patients, that means thinking of GLP-1 medication as a long-term, possibly lifetime tool - much closer to treating blood pressure than doing a 12-week “diet”.
For those who are good candidates but don’t want weekly injections, compounded sublingual semaglutide in SubMagna® HMW offers a needle-free, under-the-tongue option that can be extremely cost-effective at the same time.
Let us know how we can help. We provide the referenced compounded therapy and also readily share our approaches with healthcare providers worldwide.
Compounded medications are not reviewed by the FDA for safety or efficacy.
Four in five people put the weight back on after coming of weight loss jabs, new research has suggested today-and they're not just regaining a few pounds.